Does BIMEKIZUMAB-BKZX Cause Product distribution issue? 48 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Product distribution issue have been filed in association with BIMEKIZUMAB-BKZX. This represents 0.9% of all adverse event reports for BIMEKIZUMAB-BKZX.
48
Reports of Product distribution issue with BIMEKIZUMAB-BKZX
0.9%
of all BIMEKIZUMAB-BKZX reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product distribution issue From BIMEKIZUMAB-BKZX?
Of the 48 reports, 2 (4.2%) required hospitalization.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIMEKIZUMAB-BKZX. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does BIMEKIZUMAB-BKZX Cause?
Product dose omission issue (694)
Psoriasis (621)
Drug ineffective (402)
Product availability issue (364)
Off label use (335)
Psoriatic arthropathy (301)
Injection site pain (263)
Therapy interrupted (252)
Hidradenitis (233)
Inappropriate schedule of product administration (214)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
Which BIMEKIZUMAB-BKZX Alternatives Have Lower Product distribution issue Risk?
BIMEKIZUMAB-BKZX vs BINIMETINIB
BIMEKIZUMAB-BKZX vs BIOFLAVONOIDS
BIMEKIZUMAB-BKZX vs BIOTIN
BIMEKIZUMAB-BKZX vs BIPERIDEN
BIMEKIZUMAB-BKZX vs BIRCH TRITERPENES